On Monday, Traws Pharma Inc (NASDAQ: TRAW) opened higher 150.40% from the last session, before settling in for the closing price of $5.02. Price fluctuations for TRAW have ranged from $4.06 to $19.94 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -2.76% over the last five years. Company’s average yearly earnings per share was noted -586.00% at the time writing. With a float of $2.28 million, this company’s outstanding shares have now reached $3.03 million.
The firm has a total of 17 workers. Let’s measure their productivity. In terms of profitability, gross margin is 94.69%, operating margin of -10661.06%, and the pretax margin is -62294.25%.
Traws Pharma Inc (TRAW) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Traws Pharma Inc is 24.59%, while institutional ownership is 1.35%.
Traws Pharma Inc (TRAW) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -586.00% per share during the next fiscal year.
Traws Pharma Inc (NASDAQ: TRAW) Trading Performance Indicators
Check out the current performance indicators for Traws Pharma Inc (TRAW). In the past quarter, the stock posted a quick ratio of 1.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 155.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -141.35, a number that is poised to hit -9.55 in the next quarter and is forecasted to reach -35.52 in one year’s time.
Technical Analysis of Traws Pharma Inc (TRAW)
Analysing the last 5-days average volume posted by the [Traws Pharma Inc, TRAW], we can find that recorded value of 5.69 million was better than the volume posted last year of 0.12 million. As of the previous 9 days, the stock’s Stochastic %D was 60.26%. Additionally, its Average True Range was 1.38.
During the past 100 days, Traws Pharma Inc’s (TRAW) raw stochastic average was set at 55.33%, which indicates a significant increase from 53.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 379.21% in the past 14 days, which was higher than the 163.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.11, while its 200-day Moving Average is $11.07. Now, the first resistance to watch is $17.64. This is followed by the second major resistance level at $22.70. The third major resistance level sits at $25.97. If the price goes on to break the first support level at $9.31, it is likely to go to the next support level at $6.04. Now, if the price goes above the second support level, the third support stands at $0.98.
Traws Pharma Inc (NASDAQ: TRAW) Key Stats
There are currently 3,026K shares outstanding in the company with a market cap of 35.79 million. Presently, the company’s annual sales total 230 K according to its annual income of -18,950 K. Last quarter, the company’s sales amounted to 60 K and its income totaled -8,480 K.
